changemaker

NewsWorld Health Organization4 min read

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

In short

The World Health Organization halted specific arms of its global clinical trial evaluating treatments for hospitalized COVID-19 patients. Interim findings revealed that the tested medications failed to lower mortality rates compared to standard care.

Pro library

The three takeaways, why it matters for your work, and adding it to your page.

Studies, reports and articles picked for your craft every week, the full library, and a learning log on your page that shows your skills growing.

Black Friday price: $30 for 6 months, then $39 from 1 December. One payment, nothing renews.

Or read this week’s free picks →
Read the original (free) at World Health Organization
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 | changemaker